Insider Trading Activity For CME Group Inc. (NASDAQ:CME)
Ronald A Pankau , Director of CME Group Inc. (NASDAQ:CME) reportedly Sold 300 shares of the company’s stock at an average price of 124.78 for a total transaction amount of $37,434.00 SEC Form
Insider Trading History For CME Group Inc. (NASDAQ:CME)
Analyst Ratings For CME Group Inc. (NASDAQ:CME)
These are 2 Hold Ratings, 4 Buy Ratings .
The current consensus rating for CME Group Inc. (NASDAQ:CME) is Buy (Score: 2.67) with a consensus target price of $131.33 , a potential (5.08% upside)
Analyst Ratings History For CME Group Inc. (NASDAQ:CME)
- On 8/28/2015 Evercore ISI Boost Price Target of rating Buy with a price target of $101.00 to $104.00
- On 10/7/2015 Bank of America Corporation Upgraded rating Neutral to Buy with a price target of $102.00
- On 3/3/2016 Goldman Sachs Group, Inc. (The) Boost Price Target of rating Neutral with a price target of $93.00 to $97.00
- On 5/3/2016 Buckingham Research Initiated Coverage of rating Buy with a price target of $105.00
- On 5/19/2016 Sterne Agee CRT Initiated Coverage of rating Neutral with a price target of $90.00
- On 6/1/2016 Credit Suisse Group Lower Price Target of rating Neutral with a price target of $100.00 to $94.00
- On 7/29/2016 Barclays PLC Lower Price Target of rating Equal Weight with a price target of $100.00 to $99.00
Dividend Information For CME Group Inc. (NASDAQ:CME)
CME Group Inc. (NASDAQ:CME) pays an annual dividend of Community Ranking: with a yield of Community Ranking:
Dividend History For CME Group Inc. (NASDAQ:CME)
Recent Trading Activity for CME Group Inc. (NASDAQ:CME)
Shares of CME Group Inc. closed the previous trading session at 124.99 up +0.83 0.67% with 1,359,268 shares trading hands.